2025-04-18 - Analysis Report
## Procter & Gamble Co (PG) Stock Review

**0) Executive Summary:**

Procter & Gamble Co (PG) is a consumer goods company.  Over the analyzed period, PG significantly outperformed the S&P 500 (VOO), showing a higher cumulative return and generally positive alpha.  Recent financial data indicates consistent revenue and profitability, although recent price action shows some moderate volatility.

**1) Performance Comparison:**

Procter & Gamble (PG) shows a cumulative return of 85.65%, while the S&P 500 (VOO) shows a cumulative return of 76.18%.  This represents a difference of 9.47%, placing PG at the 56.9th percentile of its historical relative performance against the S&P 500 based on provided min/max range.

**Alpha and Beta Analysis:**

The provided data shows a generally positive alpha across the observed years (2015-2025), indicating that PG has consistently outperformed the market. Beta is consistently around 0.3 indicating that PG shows lower volatility than the market.  The CAGR (Compound Annual Growth Rate) fluctuates but generally remains above 0,  and MDD (Maximum Drawdown) is relatively manageable.  Capitalization has grown steadily over time.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 27.0% | 7.9% | -6.0% | 0.0 | 177.8 |
| 2016-2018  | 8.0% | 56.9% | -13.0% | 0.1 | 184.2 |
| 2017-2019  | 37.0% | 56.9% | 4.0% | 0.4 | 257.3 |
| 2018-2020  | 52.0% | 59.2% | 21.0% | 0.3 | 293.7 |
| 2019-2021  | 71.0% | 59.2% | 11.0% | 0.3 | 354.0 |
| 2020-2022  | 32.0% | 74.7% | 23.0% | 0.3 | 336.1 |
| 2021-2023  | 34.0% | 74.7% | 14.0% | 0.3 | 333.2 |
| 2022-2024  | 9.0% | 74.7% | -12.0% | 0.3 | 390.7 |
| 2023-2025  | 6.0% | 70.4% | -9.0% | 0.1 | 400.1 |


**2) Recent Price Action:**

* **Closing Price:** $170.63
* **5-day Moving Average:** $168.31
* **20-day Moving Average:** $166.56
* **60-day Moving Average:** $168.51

The price is slightly above the 5-day and 60-day moving averages, and significantly above the 20-day moving average, suggesting a recent price increase. The price change from the previous close ($2.55 increase) indicates a recent upward trend.

**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4223 (Medium Risk)
* **RSI:** 53.40 (Slightly above neutral; not overbought)
* **PPO:** 0.3244 (Positive, suggesting upward momentum)
* **Delta_Previous_Relative_Divergence:** +6.5 (Short-term upward trend)
* **Expected Return:** 11.9% (Long-term expected outperformance of S&P 500)


The indicators suggest a moderately positive outlook. The recent price increase (indicated by the 'change' value) supports the positive momentum observed in the other indicators.


**4) Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2025-01-22 | 1.94 | $21.88 B      |
| 2024-10-18 | 1.65 | $21.74 B      |
| 2024-04-19 | 1.56 | $20.20 B      |
| 2024-01-23 | 1.44 | $21.44 B      |
| 2023-01-22 | 1.44 | $21.44 B      |

There is a clear increase in EPS from Q4 2024 to Q1 2025.  Revenue remains relatively stable, indicating consistent performance. The repeated entry for 2025-01-22 suggests a potential data error.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue    | Profit Margin |
|-------------|-------------|---------------|
| 2024-12-31  | $21.88B    | 52.39%        |
| 2024-09-30  | $21.74B    | 52.06%        |
| 2024-06-30  | $20.53B    | 49.60%        |
| 2024-03-31  | $20.20B    | 51.20%        |
| 2023-12-31  | $21.44B    | 52.69%        |

Revenue shows some minor fluctuations but remains consistently high. Profit margins are consistently strong, hovering around 50%.

**Capital and Profitability:**

| Quarter     | Equity      | ROE           |
|-------------|-------------|---------------|
| 2024-12-31  | $51.17B    | 9.05%         |
| 2024-09-30  | $51.84B    | 7.64%         |
| 2024-06-30  | $50.29B    | 6.24%         |
| 2024-03-31  | $50.06B    | 7.50%         |
| 2023-12-31  | $48.53B    | 7.15%         |

Equity shows some fluctuation, and ROE (Return on Equity) is generally healthy, although it fluctuates from quarter to quarter.


**6) Overall Analysis:**

PG demonstrates consistent financial performance with strong revenue and profit margins.  The stock has historically outperformed the S&P 500, and the current indicators suggest continued positive momentum, albeit with some moderate risk.  The recent price increase is notable.  However, careful attention should be paid to the potential data inconsistencies in the earnings data. Long-term investors may find PG an attractive option given its consistent performance and expected outperformance of the market.  Further investigation into the duplicated data point for 2025-01-22 is recommended.
